Company description

With the corporate mission of “Protecting the Precious Human Life from Various Forms of Diseases”, HANLIM has consistently endeavored to improve the health standard of people since its establishment in 1974. And with your warm encouragements, we have grown to become a leading pharmaceutical company in the ethical drug market specialized in IMDs and Ophthalmic Products in Korea. Since 1993 we have been approved KGMP by KFDA, 2012 we have been selected as “Innovative Pharmaceutical Company” by MOH, 2016 we have been approved PIC/s GMP by MFDS. HANLIM will do its best to provide highly qualified pharmaceutical products for the future.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: APIs |Finished Dosage Forms More

Upcoming events

1 jul 2020

CPhI South East Asia 2020

1 - 3 July 2020 Bangkok, Thailand Visit us at stand TBC Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 90C63 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Hanlim Pharm Co.,Ltd.

Hanlim Pharm Co.,Ltd.

Contact information




View all contact information